This hypothesis and the possibly occurring psychological urge to fulfill family planning in a certain time in order to schedule risk-reducing surgery procedures contribute to the fact that fertility treatment and cancer risk is of particular interest for the subgroup of BRCA1/2 mutation carriers. This evidence concerns the gene BRCA1 and cancer.